James G. Barbee, MD

Original Research

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

February 22, 2011

Original Research

The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder

July 1, 2004

Original Research

Lamotrigine as an Augmentation Agent in Treatment-Resistant Depression

August 15, 2002